Hypogonadotropic hypogonadism in subjects with DAX1 mutations
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
DAX1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1; also known as NROB1, nuclear receptor subfamily 0, group B, member 1) encodes a nuclear receptor that is expressed in embryonic stem (ES) cells, steroidogenic tissues (gonads, adrenals), the ventromedial hypothalamus (VMH), and pituitary gonadotropes. Humans with DAX1 mutations develop an X-linked syndrome referred to as adrenal hypoplasia congenita (AHC). These boys typically present in infancy with adrenal failure but later fail to undergo puberty because of hypogonadotropic hypogonadism (HHG). The adrenal failure reflects a developmental abnormality in the transition of the fetal to adult zone, resulting in glucocorticoid and mineralocorticoid deficiency. The etiology of HHG involves a combined and variable deficiency of hypothalamic GnRH secretion and/or pituitary responsiveness to GnRH resulting in low LH, FSH and testosterone. Treatment with exogenous gonadotropins generally does not induce spermatogenesis. Animal models indicate that DAX1 also plays a critical role in testis development and function. As a nuclear receptor, DAX1 has been shown to function as a transcriptional repressor, particularly of pathways regulated by other nuclear receptors, such as steroidogenic factor 1 (SF1). In addition to reproductive tissues, DAX1 is also expressed at high levels in ES cells and plays a role in the maintenance of pluripotentiality. Here we review the clinical manifestations associated with DAX1 mutations as well as the evolving information about its function based on animal models and in vitro studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631
Zanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., et al. (1994) · Nature · doi:10.1038/372635a0 · Cited by 858
Lin, L., Gu, W.-X., Ozisik, G., To, W. S., Owen, C. J., Jameson, J. L., & Achermann, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0603 · Cited by 210 · cited 5×
“After other known causes (i.e., congenital adrenal hyperplasia, CAH) have been excluded, it is estimated that as many as 50% of boys with idiopathic primary adrenal insufficiency may have mutations in DAX1 (Lin et al., 2006).”
InfluentialSelf-citationMolecular mechanisms of DAX1 action
Iyer, A. K., & McCabe, E. R. B. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.018 · Cited by 193
Tabarin, A., Achermann, J. C., Recan, D., Bex, V., Bertagna, X., Christin-Maitre, S., Ito, M., Jameson, J. L., & Bouchard, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7212 · Cited by 187 · cited 2×
“He presented with isolated adrenal insufficiency and undiagnosed partial HHG, as there was sufficient testosterone to produce some masculinization at puberty (Tabarin et al., 2000).”
Self-citationDorn, C., Ou, Q., Svaren, J., Crawford, P. A., & Sadovsky, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13870 · Cited by 165
Phenotypic spectrum of mutations in DAX-1 and SF-1
Achermann, J. C., Meeks, J. J., & Larry Jameson, J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00619-0 · Cited by 163 · cited 1×
“XY patients with heterozygous SF1 mutations exhibit a range of features that can include gonadal dysgenesis and adrenal insufficiency (Achermann et al., 2001).”
Tee, M.-K., Lin, D., Sugawara, T., Holt, J. A., Guiguen, Y., Buckingham, B., Strauss, J. F., & Miller, W. L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.12.2299 · Cited by 122
Jimenez, P., Saner, K., Mayhew, B., & Rainey, W. E. (2003) · Endocrinology · doi:10.1210/en.2003-0472 · Cited by 107
Cited by
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
“Thus, both dopamine‐antagonist antipsychotic drugs and serotonergic anti‐ depressants can cause elevated prolactin levels and may induce hypogonadism.43 Opiates (see Section 2.13) are another common cause of functional CH. Importantly, the HPG axis recovers once the underlying stimulus to energy‐deficit or hyperprolac…”
BackgroundInfluentialThe effect of X-linked dosage compensation on complex trait variation
Sidorenko, J., Kassam, I., Kemper, K. E., Zeng, J., Lloyd-Jones, L. R., Montgomery, G. W., Gibson, G., Metspalu, A., Esko, T., Yang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10598-y · Cited by 82
Burckhardt, M.-A., Udhane, S. S., Marti, N., Schnyder, I., Tapia, C., Nielsen, J. E., Mullis, P. E., Rajpert-De Meyts, E., & Flück, C. E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0599 · Cited by 49
Metadata
- Authors
- Jadhav, U., Harris, R. M., & Jameson, J. L.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 346
- Issue
- 1-2
- Pages
- 65-73
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2136024105
- Cited by
- 103
- References
- 9
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypogonadotropic hypogonadism in subjects with DAX1 mutations. https://app.cochat.ai/papers/10.1016/j.mce.2011.04.017
- The paper
- Jadhav, U., Harris, R. M., & Jameson, J. L. (2011). Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2011.04.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.